Skip to main content
Bio-TechneFacility expansion

Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development

Source: Autobound Signal API · 77 signals tracked for Bio-Techne · updated

Get Bio-Techne's live signals in Claude or ChatGPT, or by API

AskWhat changed at Bio-Techne this week? Use Autobound signals for bio-techne.com.

What happened

Bio-Techne Corporation announced the opening of a new 10,000-square-foot GMP small molecule manufacturing facility in Bristol, United Kingdom.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

MINNEAPOLIS, Oct. 8, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH ), a global provider of life science tools, reagents and diagnostic products, today announced the opening of a new manufacturing facility for Good Manufacturing Practice (GMP) grade small molecules in Bristol, United Kingdom, further expanding the company's global capabilities to support the rapidly growing cell therapy market. The investment reflects Bio-Techne's commitment to helping therapy developers address one of the industry's most pressing challenges: establishing scalable, reproducible manufacturing processes that can support programs from early development through commercialization. The purpose-built 10,000-square-foot Bristol facility features five ISO-8 multifunctional cleanrooms and two ISO-7 cleanrooms dedicated to GMP small molecule manufacturing and product handling. Designed to meet the rigorous standards required for advanced cell therapy manufacturing, the facility enhances Bio-Techne's ability to provide customers with high-quality GMP materials supported by robust quality systems and reliable global supply. "As the cell therapy field continues to mature, success increasingly depends on the ability to manufacture therapies consistently and at scale," said Kim Kelderman, President and Chief Executive Officer of Bio-Techne. "Our investment in Bristol demonstrates Bio-Techne's...

Keep reading with a free account

The rest of this article, and every signal for Bio-Techne, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Facility expansion

What this signalsA bigger facility often needs new equipment, systems and services.

Takes effect
Oct 8, 2026
Location
Bristol, England, United Kingdom

More facility expansion signals at other companies

The full record

From the Signal API record

Extraction

Confidence
95%
Detected
Oct 8, 2026
signal_type
news
signal_subtype
expands_facilities

Use this data

Get every facility expansion signal for Bio-Techne and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bio-Techne this week?”

  2. Send it to your own tools

    The Signal API returns facility expansion signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/dc2d4725-652a-4db0-5f18-68d1b9d058e8 returns this record as JSON. POST /v1/companies/enrich returns every signal for bio-techne.com.

{
  "signal_id": "dc2d4725-652a-4db0-5f18-68d1b9d058e8",
  "signal_type": "news",
  "signal_subtype": "expands_facilities",
  "detected_at": "2026-10-08T12:00:00+00:00",
  "company": {
    "name": "Bio-Techne",
    "domain": "bio-techne.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/bio-techne-expands-global-gmp-manufacturing-network-with-new-bristol-facility-to-advance-scalable-cell-therapy-development-302900052.html",
    "title": "Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development",
    "excerpt": "MINNEAPOLIS , Oct. 8, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH ), a global provider of life science tools, reagents and diagnostic products, today announced the opening of a new manufacturing facility for Good Manufacturing Practice (GMP) grade small molecules in Bristol, United Kingdom, further expanding the company's global capabilities to support the rapidly growing cell therapy market. The investment reflects Bio-Techne's commitment to helping therapy developers address one of the industry's most pressing challenges: establishing scalable, reproducible manufacturing processes that can support programs from early development through commercialization. The purpose-built 10,000-square-foot Bristol facility features five ISO-8 multifunctional cleanrooms and two ISO-7 cleanrooms dedicated to GMP small molecule manufacturing and product handling. Designed to meet the rigorous standards required for advanced cell therapy manufacturing, the facility enhances Bio-Techne's ability to provide customers with high-quality GMP materials supported by robust quality systems and reliable global supply. \"As the cell therapy field continues to mature, success increasingly depends on the ability to manufacture therapies consistently and at scale,\" said Kim Kelderman, President and Chief Executive Officer of Bio-Techne. \"Our investment in Bristol demonstrates Bio-Techne's...",
    "summary": "Bio-Techne Corporation announced the opening of a new 10,000-square-foot GMP small molecule manufacturing facility in Bristol, United Kingdom.",
    "location": "Bristol, England, United Kingdom",
    "planning": false,
    "image_url": "https://mmx.prnewswire.com/media/MS402613/Bio-Techne-Logo.jpg?id=OA2987796&p=facebook",
    "confidence": 0.95,
    "published_at": "2026-10-08T12:00:00Z",
    "location_data": [
      {
        "city": "Bristol",
        "state": "England",
        "region": "Northern Europe",
        "country": "United Kingdom",
        "continent": "Europe",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-10-08",
    "article_sentence": "Bio-Techne Corporation (NASDAQ: TECH ), a global provider of life science tools, reagents and diagnostic products, today announced the opening of a new manufacturing facility for Good Manufacturing Practice (GMP) grade small molecules in Bristol, United Kingdom, further expanding the company's global capabilities to support the rapidly growing cell therapy market."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.